Yaping Ye

Dr. Yaping Ye


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2023 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
LCLi-Jie Chen
Li-Jie Chen
HLHui-Ye Liu
Hui-Ye Liu
ZXZhi-Yuan Xiao
Zhi-Yuan Xiao
TQTing Qiu
Ting Qiu
YYYaping Ye
Yaping Ye
HJHong-Li Jiao
Hong-Li Jiao
Insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3), an RNA-binding protein, is associated with tumorigenesis and progression. However, the exact molecular mechanisms of IGF2BP3 in colorectal cancer (CRC) oncogenesis, progression, and drug resistance remain unclear. This study found that IGF2BP3 was upregulated in CRC tissues. Clinically, the elevated IGF2BP3 level is predictive of a poor prognosis. Functionally, IGF2BP3 enhances CRC tumorigenesis and progression both in vitro and in vivo. Mechanistically, IGF2BP3 promotes epidermal growth factor receptor (EGFR) mRNA stability and translation and further activates the EGFR pathway by serving as a reader in an N6-methyladenosine (m6A)-dependent manner by cooperating with METTL14. Furthermore, IGF2BP3 increases the drug resistance of CRC cells to the EGFR-targeted antibody cetuximab. Taken together, our results demonstrated that IGF2BP3 was a functional and clinical oncogene of CRC. Targeting IGF2BP3 and m6A modification may therefore offer rational therapeutic targets for patients with CRC.

17 August 2023 in Oncogene
Verified
Journal Article
Open access
PDF file
YYYaping Ye
Yaping Ye
QNQi-Qi Ni
Qi-Qi Ni
QLQiao-Yan Liang
Qiao-Yan Liang
LHLi-Ling He
Li-Ling He
BQBo-Wen Qiu
Bo-Wen Qiu
YYYaping Ye
Yaping Ye
Proficient mismatch repair or microsatellite stable (pMMR/MSS) colorectal cancers (CRCs) are vastly outnumbered by deficient mismatch repair or microsatellite instability-high (dMMR/MSI-H) tumors and lack a response to immune checkpoint inhibitors (ICIs). In this study, we reported two distinct expression patterns of ASCL2 in pMMR/MSS and dMMR/MSI-H CRCs. ASCL2 is overexpressed in pMMR/MSS CRCs and maintains a stemness phenotype, accompanied by a lower density of tumor-infiltrating lymphocytes (TILs) than those in dMMR/MSI CRCs. In addition, coadministration of anti-PD-L1 antibodies facilitated T cell infiltration and provoked strong antitumor immunity and tumor regression in the MC38/shASCL2 mouse CRC model. Furthermore, overexpression of ASCL2 was associated with increased TGFB levels, which stimulate local Cancer-associated fibroblasts (CAFs) activation, inducing an immune-excluded microenvironment. Consistently, mice with deletion of Ascl2 specifically in the intestine (Villin-Cre+, Ascl2flox/flox, named Ascl2 CKO) revealed fewer activated CAFs and higher proportions of infiltrating CD8+ T cells; We further intercrossed Ascl2 CKO with ApcMin/+ model suggesting that Ascl2-deficient expression in intestinal represented an immune infiltrating environment associated with a good prognosis. Together, our findings indicated ASCL2 induces an immune excluded microenvironment by activating CAFs through transcriptionally activating TGFB, and targeting ASCL2 combined with ICIs could present a therapeutic opportunity for MSS CRCs.

27 January 2024 in Cellular and Molecular Life Sciences
Verified
Journal Article
Open access
PDF file
DZDan Zhang
Dan Zhang
QNQi-Qi Ni
Qi-Qi Ni
SWShu-Yang Wang
Shu-Yang Wang
WHWen-Feng He
Wen-Feng He
ZHZe-Xuan Hong
Ze-Xuan Hong
YYYaping Ye
Yaping Ye
The Wnt/β-catenin pathway is critical to maintaining cell fate decisions. Recent study showed that liquid–liquid-phase separation (LLPS) of Axin organized the β-catenin destruction complex condensates in a normal cellular state. Mutations inactivating the APC gene are found in approximately 80% of all human colorectal cancer (CRC). However, the molecular mechanism of the formation of β-catenin destruction complex condensates organized by Axin phase separation and how APC mutations impact the condensates are still unclear. Here, we report that the β-catenin destruction complex, which is constructed by Axin, was assembled condensates via a phase separation process in CRC cells. The key role of wild-type APC is to stabilize destruction complex condensates. Surprisingly, truncated APC did not affect the formation of condensates, and GSK 3β and CK1α were unsuccessfully recruited, preventing β-catenin phosphorylation and resulting in accumulation in the cytoplasm of CRCs. Besides, we propose that the phase separation ability of Axin participates in the nucleus translocation of β-catenin and be incorporated and concentrated into transcriptional condensates, affecting the transcriptional activity of Wnt signaling pathway.

4 May 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
XZXinke Zhang
Xinke Zhang
ZZZihan Zhao
Zihan Zhao
RWRuixuan Wang
Ruixuan Wang
HCHaohua Chen
Haohua Chen
XZXueyi Zheng
Xueyi Zheng
MCMu-Yan Cai
Mu-Yan Cai
Accurate intraoperative differentiation of primary central nervous system lymphoma (PCNSL) remains pivotal in guiding neurosurgical decisions. However, distinguishing PCNSL from other lesions, notably glioma, through frozen sections challenges pathologists. Here we sought to develop and validate a deep learning model capable of precisely distinguishing PCNSL from non-PCNSL lesions, especially glioma, using hematoxylin and eosin (H&E)-stained frozen whole-slide images. Also, we compared its performance against pathologists of varying expertise. Additionally, a human-machine fusion approach integrated both model and pathologic diagnostics. In external cohorts, LGNet achieved AUROCs of 0.965 and 0.972 in distinguishing PCNSL from glioma and AUROCs of 0.981 and 0.993 in differentiating PCNSL from non-PCNSL lesions. Outperforming several pathologists, LGNet significantly improved diagnostic performance, further augmented to some extent by fusion approach. LGNet’s proficiency in frozen section analysis and its synergy with pathologists indicate its valuable role in intraoperative diagnosis, particularly in discriminating PCNSL from glioma, alongside other lesions.

1 October 2025 in JAMA Network Open
Verified
Journal Article
Open access
PMPengcheng Ma
Pengcheng Ma
JLJinbang Li
Jinbang Li
ZZZhengyu Zhang
Zhengyu Zhang
WQWeihao Qiu
Weihao Qiu
DLDanyi Li
Danyi Li
LLli Liang
li Liang
Importance: Kidney biopsy pathology via transmission electron microscopy (TEM) is essential for diagnosing glomerular diseases, offering critical information on glomerular basement membrane (GBM) thickness, foot process (FP) number, and electron-dense deposits (EDDs). These tasks are laborious and time-consuming.Objective: To develop and validate an artificial intelligence (AI) diagnostic system, TEM image–based AI-assisted device (TEM-AID), that accurately segments and measures glomerular ultrastructures (including the GBM, FPs, and EDDs) and determines glomerular disease subtypes using TEM images.Design, Setting, and Participants: This diagnostic study used a large, multicenter cohort including 160 727 TEM images from 31 670 patients with chronic kidney disease across 6 medical centers from January 2021 to December 2023. TEM-AID was trained and validated on 26 650 patients from 1 center and tested externally on 5020 patients (5 test sets) plus a human-AI test set (454 patients representing 7 glomerular disease subtypes). Data were analyzed from January to December 2024.Exposures: TEM-AID integrates 4 modules. Segmentation combined YOLO-v8 detection, segment anything model, and human-in-the-loop refinement to segment GBMs, podocyte FPs, and EDDs. Measurement quantified GBM thickness, FP fusion degree, and EDD deposition sites. Classification used least absolute shrinkage and selection operator–selected deep learning and statistical features with a stacking classifier to diagnose 7 glomerular disease subtypes: immunoglobin A nephropathy, membranous nephropathy, lupus nephritis, diabetic nephropathy, minimal change disease, mesangial proliferative glomerulonephritis, and thin basement membrane nephropathy.Main Outcomes and Measures: Outcomes of interest were segmentation performance (mean intersection-over-union [IOU], Dice coefficient), subtype classification accuracy, area under the receiver operating characteristic curve (AUC), and human-AI diagnostic concordance.Results: A total of 31 670 patients (mean [SD] age, 43.2 [16.5] years; 17 372 [54.9%] male) contributed 160 727 TEM images for analysis. Segmentation achieved a mean (SD) IOU of 0.835 (0.062) and Dice of 0.874 (0.023). Subtype classification accuracy was 0.911 (95% CI, 0.904-0.918) in internal validation and 0.895 to 0.914 in external tests. Macro-AUC ranged from 0.972 to 0.989 across cohorts. In human-AI testing (454 patients), TEM-AID accuracy (0.886 (95% CI, 0.859-0.912]; AUC, 0.963 [95% CI, 0.937-0.989]) exceeded clinicians’ unaided performance. Clinicians’ accuracy improved by a mean (SD) of 11.7% (5.2%) when they used TEM-AID.Conclusions and Relevance: In this multicenter diagnostic study, TEM-AID precisely quantified glomerular ultrastructures and determined glomerular disease subtypes from TEM images, significantly enhancing diagnostic efficiency and accuracy. This system provides quantitative evaluation tools to support clinical pathologists in diagnostic workflows, demonstrating robust multicenter performance.

21 May 2026 in Advanced Science
Verified
Journal Article
Open access
PDF file
XQXingtu Qin
Xingtu Qin
QLQiong Li
Qiong Li
XXXuemei Xu
Xuemei Xu
YWYuhan Wu
Yuhan Wu
YZYin Zhu
Yin Zhu
HJHongli Jiao
Hongli Jiao
A challenge in treating colorectal cancer (CRC) is the resistance of mismatch repair‐proficient or microsatellite stable (MSS) tumors to immune checkpoint inhibitors (ICIs). Tumor‐associated macrophages (TAMs) are among key drivers of this resistance. Phospholipase D3 (PLD3) is mainly expressed in macrophages, and PLD3+ macrophage (PLD3+Macro) influences immunotherapeutic efficacy and patient prognosis. We sought to define the role of PLD3 in regulating macrophage phenotypes, CRC progression, and immunotherapeutic response, and to identify potential agents target PLD3. Immunofluorescence revealed that the spatial infiltration dynamics of PLD3+Macro dictate immunotherapy resistance in CRC. We generated myeloid‐specific Pld3‐knockout mice. Using single‐cell RNA sequencing (scRNA‐seq) and flow cytometry, we delineated the impact of PLD3 on the tumor microenvironment (TME). RNA sequencing (RNA‐seq) and mass spectrometry were applied to explore the role of PLD3 in macrophages. By integrating molecular docking with tumor models, we assessed the therapeutic potential of targeting macrophage‐specific PLD3 in tumor progression and immunotherapy resistance. Collectively, PLD3 promotes tumor progression and immunotherapy resistance by modulating lysosomal‐AKT‐NF‐κB axis, thereby driving macrophage senescence and anti‐inflammatory phenotype. This is accompanied by dysregulated crosstalk from macrophages to NK and T cells, ultimately forming an immunosuppressive TME. Abrine targets PLD3 in macrophages and effectively enhances immunotherapy response in CRC.